Hsu C L, Wang H M, Lee C S, Liao C T, Chen T C
Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Am J Clin Oncol. 1998 Aug;21(4):362-5. doi: 10.1097/00000421-199808000-00009.
Most patients with hypopharyngeal carcinomas show advanced disease, either at the primary site or in the neck, at the time of diagnosis. Despite intensive therapy, a great number of recurrences and distant metastases can be observed. The most common metastatic sites are the lung and bone, and only in autopsy cases has peritoneum carcinomatosis been mentioned as a metastatic site. Since January 1992, two of 78 patients (2.3%) with advanced hypopharyngeal squamous cell carcinomas (SCCs) treated initially by chemotherapy in our department developed clinical peritoneal carcinomatosis during their natural courses. Both patients were man patients with advanced locoregional disease at stage T4N3. Their clinical peritoneal carcinomatosis appeared during chemotherapy, with good disease control above the clavicle. Both patients eventually died of sepsis within 1 month after diagnosis of the peritoneal carcinomatosis. The authors suggest that peritoneal carcinomatosis is not as rare as previously believed, and should be included in the differential diagnosis in patients with advanced hypopharyngeal SCC with abdominal symptoms. Peritoneal carcinomatosis appears to be refractory to chemotherapy, and carried a poor prognosis in patients in the present study.
大多数下咽癌患者在诊断时,原发部位或颈部均表现为晚期疾病。尽管进行了强化治疗,但仍可观察到大量复发和远处转移情况。最常见的转移部位是肺和骨,只有在尸检病例中,腹膜癌病才被提及为转移部位。自1992年1月以来,在我们科室最初接受化疗的78例晚期下咽鳞状细胞癌(SCC)患者中,有2例(2.3%)在其自然病程中出现了临床腹膜癌病。两名患者均为男性,处于T4N3期的晚期局部区域疾病。他们的临床腹膜癌病在化疗期间出现,锁骨上方疾病得到良好控制。两名患者最终均在腹膜癌病诊断后1个月内死于败血症。作者认为,腹膜癌病并不像之前认为的那样罕见,对于有腹部症状的晚期下咽SCC患者,应将其纳入鉴别诊断。腹膜癌病似乎对化疗难治,在本研究患者中预后较差。